Physician

Mark H Hermanoff, MD

According to 2025 Medicare claims, Mark Hermanoff, MD (NPI: 1447309786) practices allergy/immunology in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Waukesha, WI. This provider's primary affiliated billing organization is AURORA ADVANCED HEALTHCARE, INC. (NPI: 1265629133; TIN: 391595302) and primary practice location at 53066-4899. Hermanoff is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Hermanoff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 27,711 HCPCS/CPT codes, and received $740,896 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,611 prescription claims across 456 beneficiaries totaling $948,244 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 26 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $37,539 to $740,896. Similarly, Part D prescription costs have risen steadily, from $373,530 to $948,244. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,213 and ending at $542.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	256	2,107	$37,539
2016	261	2,720	$52,046
2017	289	3,131	$54,562
2018	326	7,758	$157,157
2019	295	10,298	$245,078
2020	275	10,240	$272,432
2021	281	15,446	$369,353
2022	280	16,948	$462,166
2023	262	18,818	$523,896
2024	276	27,711	$740,896

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	260	1,834	$373,530
2016	293	2,095	$529,434
2017	291	1,830	$547,857
2018	334	2,088	$574,389
2019	344	2,059	$529,313
2020	341	2,046	$576,089
2021	351	2,009	$520,746
2022	383	2,203	$760,747
2023	419	2,203	$844,757
2024	456	2,611	$948,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$2,820
2016	N/R	12	$310
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	33	$764
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	26	$82,896
2024	N/R	26	$83,676

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	63	63	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	90	110	$84
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	46	46	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	120	133	$59
94010	Test to measure expiratory airflow and volume	85	89	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	71	1,946	$272,974
Xolair	Omalizumab	42	1,186	$160,235
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	82	3,120	$64,469
Arnuity Ellipta	Fluticasone Furoate	156	7,140	$59,609
Spiriva Respimat	Tiotropium Bromide	91	3,450	$58,366

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$83,542
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark H. Hermanoff, MD?

Tedicare shows public-source Medicare data for Mark H. Hermanoff, MD (NPI 1447309786), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark H. Hermanoff, MD have ACO affiliation data?

Mark H. Hermanoff, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Mark H. Hermanoff, MD?

Mark H. Hermanoff, MD is linked to AURORA ADVANCED HEALTHCARE, INC. (billing NPI 1265629133) in the available physician profile data.

Does Mark H. Hermanoff, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.